Skip to main content
Joshi Alumkal, MD, Oncology, Ann Arbor, MI

JoshiJAlumkalMD

Oncology • Ann Arbor, MI

Genitourinary Oncology, Hematologic Oncology

Leader of the Prostate and Genitourinary Medical Oncology Section; Professor of Internal Medicine, University of Michigan Medical Center

Join to view full profile

Dr. Alumkal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Alumkal's full profile

Already have an account?

  • Office

    1500 E Medical Center Dr
    Rogel Cancer Center
    Ann Arbor, MI 48109

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2002 - 2006
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1998 - 2002
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1998

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2019 - 2026
  • OR State Medical License
    OR State Medical License 2006 - 2021
  • MD State Medical License
    MD State Medical License 2002 - 2008
  • TX State Medical License
    TX State Medical License 2000 - 2006
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Maintenance and Pharmacologic Targeting of ROR1 Protein Levels via UHRF1 in T(1;19) Pre-B-ALL  
    Joshi Alumkal, MD, Nature

Press Mentions

  • Damon Runyon Cancer Research Foundation Awards $4.8 Million to Rising Investigators
    Damon Runyon Cancer Research Foundation Awards $4.8 Million to Rising InvestigatorsJuly 15th, 2021
  • BET Inhibitors May Help Overcome a Newly Recognized Form of Resistance to Prostate Cancer Drugs
    BET Inhibitors May Help Overcome a Newly Recognized Form of Resistance to Prostate Cancer DrugsJune 20th, 2021
  • BET Inhibitors Show Promise in Overcoming Lineage Plasticity, a Newly Recognized Form of Resistance to Prostate Cancer Drugs
    BET Inhibitors Show Promise in Overcoming Lineage Plasticity, a Newly Recognized Form of Resistance to Prostate Cancer DrugsJune 18th, 2021
  • Join now to see all

Professional Memberships

Dr. Joshi Alumkal, Dr. Joshi Alumkal, MD, Dr. J Alumkal, Dr. Joshi J Alumkal